<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1997-11-01" modified="2020-10-07" version="197">
<accession>Q92985</accession>
<accession>B9EGL3</accession>
<accession>O00331</accession>
<accession>O00332</accession>
<accession>O00333</accession>
<accession>O75924</accession>
<accession>Q9UE79</accession>
<name>IRF7_HUMAN</name>
<protein>
<recommendedName>
<fullName>Interferon regulatory factor 7</fullName>
<shortName>IRF-7</shortName>
</recommendedName>
</protein>
<gene>
<name type="primary">IRF7</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="submission" date="1996-10" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Grossman A."/>
<person name="Nicholl J."/>
<person name="Antonio L."/>
<person name="Luethy R."/>
<person name="Suggs S."/>
<person name="Sutherland G.R."/>
<person name="Mak T.W."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A)</scope>
<scope>VARIANT GLU-179</scope>
<source>
<tissue>Spleen</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="Mol. Cell. Biol." volume="17" first="5748" last="5757">
<title>IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency.</title>
<authorList>
<person name="Zhang L."/>
<person name="Pagano J.S."/>
</authorList>
<dbReference type="PubMed" id="9315633"/>
<dbReference type="DOI" id="10.1128/mcb.17.10.5748"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A; B AND C)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="29210" last="29217">
<title>Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes.</title>
<authorList>
<person name="Au W.-C."/>
<person name="Moore P.A."/>
<person name="LaFleur D.W."/>
<person name="Tombal B."/>
<person name="Pitha P.M."/>
</authorList>
<dbReference type="PubMed" id="9786932"/>
<dbReference type="DOI" id="10.1074/jbc.273.44.29210"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM D)</scope>
<scope>VARIANTS GLU-179 AND ARG-412</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM D)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="8803" last="8814">
<title>Phosphorylation-induced dimerization of interferon regulatory factor 7 unmasks DNA binding and a bipartite transactivation domain.</title>
<authorList>
<person name="Marie I.J."/>
<person name="Smith E."/>
<person name="Prakash A."/>
<person name="Levy D.E."/>
</authorList>
<dbReference type="PubMed" id="11073981"/>
<dbReference type="DOI" id="10.1128/mcb.20.23.8803-8814.2000"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="8951" last="8957">
<title>IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or Ikappa B kinase but is blocked by Vaccinia virus E3L protein.</title>
<authorList>
<person name="Smith E.J."/>
<person name="Marie I.J."/>
<person name="Prakash A."/>
<person name="Garcia-Sastre A."/>
<person name="Levy D.E."/>
</authorList>
<dbReference type="PubMed" id="11124948"/>
<dbReference type="DOI" id="10.1074/jbc.m008717200"/>
</citation>
<scope>INHIBITION OF PHOSPHORYLATION BY VACCINIA VIRUS PROTEIN E3</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2001" name="Oncogene" volume="20" first="800" last="811">
<title>HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators.</title>
<authorList>
<person name="Lin R."/>
<person name="Genin P."/>
<person name="Mamane Y."/>
<person name="Sgarbanti M."/>
<person name="Battistini A."/>
<person name="Harrington W.J. Jr."/>
<person name="Barber G.N."/>
<person name="Hiscott J."/>
</authorList>
<dbReference type="PubMed" id="11314014"/>
<dbReference type="DOI" id="10.1038/sj.onc.1204163"/>
</citation>
<scope>INTERACTION WITH HHV-8 PROTEIN VIRF1</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="49417" last="49421">
<title>Acetylation of interferon regulatory factor-7 by p300/CREB-binding protein (CBP)-associated factor (PCAF) impairs its DNA binding.</title>
<authorList>
<person name="Caillaud A."/>
<person name="Prakash A."/>
<person name="Smith E."/>
<person name="Masumi A."/>
<person name="Hovanessian A.G."/>
<person name="Levy D.E."/>
<person name="Marie I."/>
</authorList>
<dbReference type="PubMed" id="12374802"/>
<dbReference type="DOI" id="10.1074/jbc.m207484200"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACETYLATION AT LYS-92</scope>
<scope>MUTAGENESIS OF GLY-90; LYS-92 AND THR-93</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2002" name="J. Interferon Cytokine Res." volume="22" first="95" last="101">
<title>Structure and function of IRF-7.</title>
<authorList>
<person name="Zhang L."/>
<person name="Pagano J.S."/>
</authorList>
<dbReference type="PubMed" id="11846980"/>
<dbReference type="DOI" id="10.1089/107999002753452700"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="5573" last="5578">
<title>A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation.</title>
<authorList>
<person name="Zhu F.X."/>
<person name="King S.M."/>
<person name="Smith E.J."/>
<person name="Levy D.E."/>
<person name="Yuan Y."/>
</authorList>
<dbReference type="PubMed" id="11943871"/>
<dbReference type="DOI" id="10.1073/pnas.082420599"/>
</citation>
<scope>INTERACTION WITH HHV-8 PROTEIN ORF45 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2003" name="J. Exp. Med." volume="198" first="1043" last="1055">
<title>LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF.</title>
<authorList>
<person name="Fitzgerald K.A."/>
<person name="Rowe D.C."/>
<person name="Barnes B.J."/>
<person name="Caffrey D.R."/>
<person name="Visintin A."/>
<person name="Latz E."/>
<person name="Monks B."/>
<person name="Pitha P.M."/>
<person name="Golenbock D.T."/>
</authorList>
<dbReference type="PubMed" id="14517278"/>
<dbReference type="DOI" id="10.1084/jem.20031023"/>
</citation>
<scope>INTERACTION WITH TICAM2</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="J. Exp. Med." volume="198" first="1451" last="1451">
<authorList>
<person name="Fitzgerald K.A."/>
<person name="Rowe D.C."/>
<person name="Barnes B.J."/>
<person name="Caffrey D.R."/>
<person name="Visintin A."/>
<person name="Latz E."/>
<person name="Monks B."/>
<person name="Pitha P.M."/>
<person name="Golenbock D.T."/>
</authorList>
</citation>
<scope>ERRATUM OF PUBMED:14517278</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="15652" last="15661">
<title>Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways.</title>
<authorList>
<person name="Han K.J."/>
<person name="Su X."/>
<person name="Xu L.-G."/>
<person name="Bin L.H."/>
<person name="Zhang J."/>
<person name="Shu H.-B."/>
</authorList>
<dbReference type="PubMed" id="14739303"/>
<dbReference type="DOI" id="10.1074/jbc.m311629200"/>
</citation>
<scope>INTERACTION WITH TICAM1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="Genome Biol." volume="5" first="R8.1" last="R8.16">
<title>An unappreciated role for RNA surveillance.</title>
<authorList>
<person name="Hillman R.T."/>
<person name="Green R.E."/>
<person name="Brenner S.E."/>
</authorList>
<dbReference type="PubMed" id="14759258"/>
<dbReference type="DOI" id="10.1186/gb-2004-5-2-r8"/>
</citation>
<scope>SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S)</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2004" name="J. Virol." volume="78" first="10636" last="10649">
<title>Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity.</title>
<authorList>
<person name="tenOever B.R."/>
<person name="Sharma S."/>
<person name="Zou W."/>
<person name="Sun Q."/>
<person name="Grandvaux N."/>
<person name="Julkunen I."/>
<person name="Hemmi H."/>
<person name="Yamamoto M."/>
<person name="Akira S."/>
<person name="Yeh W.C."/>
<person name="Lin R."/>
<person name="Hiscott J."/>
</authorList>
<dbReference type="PubMed" id="15367631"/>
<dbReference type="DOI" id="10.1128/jvi.78.19.10636-10649.2004"/>
</citation>
<scope>PHOSPHORYLATION AT SER-477 AND SER-479 BY TBK1 AND IKKE</scope>
<scope>MUTAGENESIS OF 477-SER--SER-479</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="15416" last="15421">
<title>Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling.</title>
<authorList>
<person name="Honda K."/>
<person name="Yanai H."/>
<person name="Mizutani T."/>
<person name="Negishi H."/>
<person name="Shimada N."/>
<person name="Suzuki N."/>
<person name="Ohba Y."/>
<person name="Takaoka A."/>
<person name="Yeh W.C."/>
<person name="Taniguchi T."/>
</authorList>
<dbReference type="PubMed" id="15492225"/>
<dbReference type="DOI" id="10.1073/pnas.0406933101"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH MYD88</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2004" name="Nat. Immunol." volume="5" first="1061" last="1068">
<title>Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6.</title>
<authorList>
<person name="Kawai T."/>
<person name="Sato S."/>
<person name="Ishii K.J."/>
<person name="Coban C."/>
<person name="Hemmi H."/>
<person name="Yamamoto M."/>
<person name="Terai K."/>
<person name="Matsuda M."/>
<person name="Inoue J."/>
<person name="Uematsu S."/>
<person name="Takeuchi O."/>
<person name="Akira S."/>
</authorList>
<dbReference type="PubMed" id="15361868"/>
<dbReference type="DOI" id="10.1038/ni1118"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH MYD88 AND TRAF6</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2005" name="J. Exp. Med." volume="201" first="915" last="923">
<title>Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.</title>
<authorList>
<person name="Uematsu S."/>
<person name="Sato S."/>
<person name="Yamamoto M."/>
<person name="Hirotani T."/>
<person name="Kato H."/>
<person name="Takeshita F."/>
<person name="Matsuda M."/>
<person name="Coban C."/>
<person name="Ishii K.J."/>
<person name="Kawai T."/>
<person name="Takeuchi O."/>
<person name="Akira S."/>
</authorList>
<dbReference type="PubMed" id="15767370"/>
<dbReference type="DOI" id="10.1084/jem.20042372"/>
</citation>
<scope>PHOSPHORYLATION BY IRAK1</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2006" name="Biochem. Pharmacol." volume="72" first="1469" last="1476">
<title>Distinct functions of IRF-3 and IRF-7 in IFN-alpha gene regulation and control of anti-tumor activity in primary macrophages.</title>
<authorList>
<person name="Solis M."/>
<person name="Goubau D."/>
<person name="Romieu-Mourez R."/>
<person name="Genin P."/>
<person name="Civas A."/>
<person name="Hiscott J."/>
</authorList>
<dbReference type="PubMed" id="16846591"/>
<dbReference type="DOI" id="10.1016/j.bcp.2006.06.002"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2006" name="Immunity" volume="25" first="349" last="360">
<title>Type I interferon gene induction by the interferon regulatory factor family of transcription factors.</title>
<authorList>
<person name="Honda K."/>
<person name="Takaoka A."/>
<person name="Taniguchi T."/>
</authorList>
<dbReference type="PubMed" id="16979567"/>
<dbReference type="DOI" id="10.1016/j.immuni.2006.08.009"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2006" name="Immunity" volume="25" first="849" last="849">
<authorList>
<person name="Honda K."/>
<person name="Takaoka A."/>
<person name="Taniguchi T."/>
</authorList>
</citation>
<scope>ERRATUM OF PUBMED:16979567</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2007" name="Ann. N. Y. Acad. Sci." volume="1095" first="325" last="333">
<title>IRF-7: new role in the regulation of genes involved in adaptive immunity.</title>
<authorList>
<person name="Sgarbanti M."/>
<person name="Marsili G."/>
<person name="Remoli A.L."/>
<person name="Orsatti R."/>
<person name="Battistini A."/>
</authorList>
<dbReference type="PubMed" id="17404045"/>
<dbReference type="DOI" id="10.1196/annals.1397.036"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2007" name="J. Virol." volume="81" first="4473" last="4481">
<title>Rotavirus NSP1 inhibits expression of type I interferon by antagonizing the function of interferon regulatory factors IRF3, IRF5, and IRF7.</title>
<authorList>
<person name="Barro M."/>
<person name="Patton J.T."/>
</authorList>
<dbReference type="PubMed" id="17301153"/>
<dbReference type="DOI" id="10.1128/jvi.02498-06"/>
</citation>
<scope>INTERACTION WITH ROTAVIRUS A NSP1 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="18448" last="18453">
<title>IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3.</title>
<authorList>
<person name="Song Y.J."/>
<person name="Izumi K.M."/>
<person name="Shinners N.P."/>
<person name="Gewurz B.E."/>
<person name="Kieff E."/>
</authorList>
<dbReference type="PubMed" id="19017798"/>
<dbReference type="DOI" id="10.1073/pnas.0809933105"/>
</citation>
<scope>INTERACTION WITH EPSTEIN-BARR VIRUS/EBV LMP1 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="J. Virol." volume="83" first="1140" last="1146">
<title>Epstein-Barr virus LF2: an antagonist to type I interferon.</title>
<authorList>
<person name="Wu L."/>
<person name="Fossum E."/>
<person name="Joo C.H."/>
<person name="Inn K.S."/>
<person name="Shin Y.C."/>
<person name="Johannsen E."/>
<person name="Hutt-Fletcher L.M."/>
<person name="Hass J."/>
<person name="Jung J.U."/>
</authorList>
<dbReference type="PubMed" id="18987133"/>
<dbReference type="DOI" id="10.1128/jvi.00602-08"/>
</citation>
<scope>INTERACTION WITH EPSTEIN-BARR VIRUS/EBV LF2 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2010" name="Cancer Immunol. Immunother." volume="59" first="489" last="510">
<title>Regulation of immunity and oncogenesis by the IRF transcription factor family.</title>
<authorList>
<person name="Savitsky D."/>
<person name="Tamura T."/>
<person name="Yanai H."/>
<person name="Taniguchi T."/>
</authorList>
<dbReference type="PubMed" id="20049431"/>
<dbReference type="DOI" id="10.1007/s00262-009-0804-6"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2011" name="Genes Immun." volume="12" first="399" last="414">
<title>IRF7: activation, regulation, modification and function.</title>
<authorList>
<person name="Ning S."/>
<person name="Pagano J.S."/>
<person name="Barber G.N."/>
</authorList>
<dbReference type="PubMed" id="21490621"/>
<dbReference type="DOI" id="10.1038/gene.2011.21"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2011" name="J. Immunol." volume="187" first="4754" last="4763">
<title>Tripartite motif-containing protein 28 is a small ubiquitin-related modifier E3 ligase and negative regulator of IFN regulatory factor 7.</title>
<authorList>
<person name="Liang Q."/>
<person name="Deng H."/>
<person name="Li X."/>
<person name="Wu X."/>
<person name="Tang Q."/>
<person name="Chang T.H."/>
<person name="Peng H."/>
<person name="Rauscher F.J. III"/>
<person name="Ozato K."/>
<person name="Zhu F."/>
</authorList>
<dbReference type="PubMed" id="21940674"/>
<dbReference type="DOI" id="10.4049/jimmunol.1101704"/>
</citation>
<scope>SUMOYLATION AT LYS-444 AND LYS-446 BY TRIM28</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2016" name="J. Virol." volume="90" first="1613" last="1621">
<title>3C Protease of Enterovirus D68 Inhibits Cellular Defense Mediated by Interferon Regulatory Factor 7.</title>
<authorList>
<person name="Xiang Z."/>
<person name="Liu L."/>
<person name="Lei X."/>
<person name="Zhou Z."/>
<person name="He B."/>
<person name="Wang J."/>
</authorList>
<dbReference type="PubMed" id="26608321"/>
<dbReference type="DOI" id="10.1128/jvi.02395-15"/>
</citation>
<scope>PROTEOLYTIC CLEAVAGE (MICROBIAL INFECTION)</scope>
<scope>MUTAGENESIS OF GLN-167 AND GLN-189</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2017" name="J. Virol." volume="91">
<title>Positive and Negative Regulation of Type I Interferons by the Human T Cell Leukemia Virus Antisense Protein HBZ.</title>
<authorList>
<person name="Narulla M.S."/>
<person name="Alasiri A."/>
<person name="Charmier L."/>
<person name="Noonan S."/>
<person name="Conroy D."/>
<person name="Hall W.W."/>
<person name="Sheehy N."/>
</authorList>
<dbReference type="PubMed" id="28768861"/>
<dbReference type="DOI" id="10.1128/jvi.00853-17"/>
</citation>
<scope>INTERACTION WITH HUMAN T-CELL LEUKEMIA VIRUS 1/HTLV-1 PROTEIN HBZ (MICROBIAL INFECTION)</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2013" name="J. Virol." volume="87" first="1690" last="1698">
<title>Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses.</title>
<authorList>
<person name="Lei X."/>
<person name="Xiao X."/>
<person name="Xue Q."/>
<person name="Jin Q."/>
<person name="He B."/>
<person name="Wang J."/>
</authorList>
<dbReference type="PubMed" id="23175366"/>
<dbReference type="DOI" id="10.1128/jvi.01855-12"/>
</citation>
<scope>PROTEOLYTIC CLEAVAGE (MICROBIAL INFECTION)</scope>
<scope>MUTAGENESIS OF GLN-151; GLN-167; GLN-185; GLN-188; GLN-189 AND GLN-215</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2018" name="Virology" volume="518" first="1" last="7">
<title>Seneca Valley Virus 3Cpro abrogates the IRF3- and IRF7-mediated innate immune response by degrading IRF3 and IRF7.</title>
<authorList>
<person name="Xue Q."/>
<person name="Liu H."/>
<person name="Zhu Z."/>
<person name="Yang F."/>
<person name="Ma L."/>
<person name="Cai X."/>
<person name="Xue Q."/>
<person name="Zheng H."/>
</authorList>
<dbReference type="PubMed" id="29427864"/>
<dbReference type="DOI" id="10.1016/j.virol.2018.01.028"/>
</citation>
<scope>INTERACTION WITH SENECA VALLEY VIRUS PROTEASE 3C (MICROBIAL INFECTION)</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2015" name="Science" volume="348" first="448" last="453">
<title>Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency.</title>
<authorList>
<person name="Ciancanelli M.J."/>
<person name="Huang S.X."/>
<person name="Luthra P."/>
<person name="Garner H."/>
<person name="Itan Y."/>
<person name="Volpi S."/>
<person name="Lafaille F.G."/>
<person name="Trouillet C."/>
<person name="Schmolke M."/>
<person name="Albrecht R.A."/>
<person name="Israelsson E."/>
<person name="Lim H.K."/>
<person name="Casadio M."/>
<person name="Hermesh T."/>
<person name="Lorenzo L."/>
<person name="Leung L.W."/>
<person name="Pedergnana V."/>
<person name="Boisson B."/>
<person name="Okada S."/>
<person name="Picard C."/>
<person name="Ringuier B."/>
<person name="Troussier F."/>
<person name="Chaussabel D."/>
<person name="Abel L."/>
<person name="Pellier I."/>
<person name="Notarangelo L.D."/>
<person name="Garcia-Sastre A."/>
<person name="Basler C.F."/>
<person name="Geissmann F."/>
<person name="Zhang S.Y."/>
<person name="Snoeck H.W."/>
<person name="Casanova J.L."/>
</authorList>
<dbReference type="PubMed" id="25814066"/>
<dbReference type="DOI" id="10.1126/science.aaa1578"/>
</citation>
<scope>INVOLVEMENT IN IMD39</scope>
<scope>VARIANT IMD39 VAL-410</scope>
<scope>CHARACTERIZATION OF VARIANT IMD39 VAL-410</scope>
</reference>
<comment type="function">
<text evidence="3 5 8 11 16">Key transcriptional regulator of type I interferon (IFN)-dependent immune responses and plays a critical role in the innate immune response against DNA and RNA viruses. Regulates the transcription of type I IFN genes (IFN-alpha and IFN-beta) and IFN-stimulated genes (ISG) by binding to an interferon-stimulated response element (ISRE) in their promoters. Can efficiently activate both the IFN-beta (IFNB) and the IFN-alpha (IFNA) genes and mediate their induction via both the virus-activated, MyD88-independent pathway and the TLR-activated, MyD88-dependent pathway. Induces transcription of ubiquitin hydrolase USP25 mRNA in response to lipopolysaccharide (LPS) or viral infection in a type I IFN-dependent manner (By similarity). Required during both the early and late phases of the IFN gene induction but is more critical for the late than for the early phase. Exists in an inactive form in the cytoplasm of uninfected cells and following viral infection, double-stranded RNA (dsRNA), or toll-like receptor (TLR) signaling, becomes phosphorylated by IKBKE and TBK1 kinases. This induces a conformational change, leading to its dimerization and nuclear localization where along with other coactivators it can activate transcription of the type I IFN and ISG genes. Can also play a role in regulating adaptive immune responses by inducing PSMB9/LMP2 expression, either directly or through induction of IRF1. Binds to the Q promoter (Qp) of EBV nuclear antigen 1 a (EBNA1) and may play a role in the regulation of EBV latency. Can activate distinct gene expression programs in macrophages and regulate the anti-tumor properties of primary macrophages.</text>
</comment>
<comment type="activity regulation">
<text>In the absence of viral infection, maintained as a monomer in an autoinhibited state and phosphorylation disrupts this autoinhibition leading to the liberation of the DNA-binding and dimerization activities and its nuclear localization where it can activate type I IFN and ISG genes.</text>
</comment>
<comment type="subunit">
<text evidence="5 6 9 10 11 13">Monomer. Homodimer; phosphorylation-induced. Heterodimer with IRF3. Interacts with TICAM1 and TICAM2. Interacts with MYD88 and TRAF6.</text>
</comment>
<comment type="subunit">
<text evidence="17 18">(Microbial infection) Interacts with Epstein-Barr virus LF2 and LMP1.</text>
</comment>
<comment type="subunit">
<text evidence="15">(Microbial infection) Interacts with rotavirus A NSP1; this interaction leads to the proteasome-dependent degradation of IRF7.</text>
</comment>
<comment type="subunit">
<text evidence="7">(Microbial infection) Interacts with human herpes virus 8/HHV-8 proteins ORF45 and vIRF-1.</text>
</comment>
<comment type="subunit">
<text evidence="23">(Microbial infection) Interacts with human T-cell leukemia virus 1/HTLV-1 protein HBZ.</text>
</comment>
<comment type="subunit">
<text evidence="24">(Microbial infection) Interacts with Seneca Valley virus protease 3C; this interaction is involved in the suppression of IRF7 expression and phosphorylation by the virus.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-968267">
<id>Q92985</id>
</interactant>
<interactant intactId="EBI-704197">
<id>O00170</id>
<label>AIP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-968267">
<id>Q92985</id>
</interactant>
<interactant intactId="EBI-365961">
<id>P10398</id>
<label>ARAF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-968267">
<id>Q92985</id>
</interactant>
<interactant intactId="EBI-720151">
<id>Q96A33</id>
<label>CCDC47</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-968267">
<id>Q92985</id>
</interactant>
<interactant intactId="EBI-81249">
<id>O15111</id>
<label>CHUK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-968267">
<id>Q92985</id>
</interactant>
<interactant intactId="EBI-358664">
<id>P51617</id>
<label>IRAK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-968267">
<id>Q92985</id>
</interactant>
<interactant intactId="EBI-1044684">
<id>O94822</id>
<label>LTN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-968267">
<id>Q92985</id>
</interactant>
<interactant intactId="EBI-3957166">
<id>Q9ULE6</id>
<label>PALD1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-968267">
<id>Q92985</id>
</interactant>
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
<label>TBK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-968267">
<id>Q92985</id>
</interactant>
<interactant intactId="EBI-1047967">
<id>Q86UE8</id>
<label>TLK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-968267">
<id>Q92985</id>
</interactant>
<interactant intactId="EBI-3197877">
<id>Q9BVS5</id>
<label>TRMT61B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-968267">
<id>Q92985</id>
</interactant>
<interactant intactId="EBI-11292028">
<id>P29128</id>
<label>BICP0</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-968267">
<id>Q92985</id>
</interactant>
<interactant intactId="EBI-8843990">
<id>F5HDE4</id>
<label>ORF45</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-968267">
<id>Q92985</id>
</interactant>
<interactant intactId="EBI-6149376">
<id>Q77M19</id>
<label>P</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-8850881">
<id>Q92985-1</id>
</interactant>
<interactant intactId="EBI-6973030">
<id>P03230</id>
<label>LMP1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<text>The phosphorylated and active form accumulates selectively in the nucleus.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q92985-1</id>
<name>A</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q92985-2</id>
<name>B</name>
<name>Beta</name>
<sequence type="described" ref="VSP_002760"/>
</isoform>
<isoform>
<id>Q92985-3</id>
<name>C</name>
<name>Gamma</name>
<sequence type="described" ref="VSP_002758 VSP_002759"/>
</isoform>
<isoform>
<id>Q92985-4</id>
<name>D</name>
<name>H</name>
<sequence type="described" ref="VSP_002757"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Expressed predominantly in spleen, thymus and peripheral blood leukocytes.</text>
</comment>
<comment type="induction">
<text>By type I interferon (IFN) and viruses.</text>
</comment>
<comment type="PTM">
<text evidence="8">Acetylation inhibits its DNA-binding ability and activity.</text>
</comment>
<comment type="PTM">
<text evidence="5 8 12 14">In response to a viral infection, phosphorylated on Ser-477 and Ser-479 by TBK1 and IKBKE1. Phosphorylation, and subsequent activation is inhibited by vaccinia virus protein E3. In TLR7- and TLR9-mediated signaling pathway, phosphorylated by IRAK1.</text>
</comment>
<comment type="PTM">
<text evidence="2">TRAF6-mediated ubiquitination is required for IRF7 activation.</text>
</comment>
<comment type="PTM">
<text evidence="19">Sumoylated by TRIM28, which inhibits its transactivation activity.</text>
</comment>
<comment type="PTM">
<text evidence="20">(Microbial infection) Cleaved and inactivated by the protease 3C of enterovirus 71 allowing the virus to disrupt the host type I interferon production.</text>
</comment>
<comment type="PTM">
<text evidence="22">(Microbial infection) Cleaved and inactivated by the protease 3C of human enterovirus 68D (EV68) allowing the virus to disrupt the host type I interferon production.</text>
</comment>
<comment type="disease" evidence="21">
<disease id="DI-04423">
<name>Immunodeficiency 39</name>
<acronym>IMD39</acronym>
<description>A primary immunodeficiency causing severe, life-threatening acute respiratory distress upon infection with H1N1 influenza A.</description>
<dbReference type="MIM" id="616345"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform C</molecule>
<text evidence="30">May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.</text>
</comment>
<comment type="similarity">
<text evidence="4">Belongs to the IRF family.</text>
</comment>
<dbReference type="EMBL" id="U73036">
<property type="protein sequence ID" value="AAB17190.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U53830">
<property type="protein sequence ID" value="AAB80686.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U53831">
<property type="protein sequence ID" value="AAB80688.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U53832">
<property type="protein sequence ID" value="AAB80690.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U53832">
<property type="protein sequence ID" value="AAB80691.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF076494">
<property type="protein sequence ID" value="AAC70999.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471158">
<property type="protein sequence ID" value="EAX02360.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC136555">
<property type="protein sequence ID" value="AAI36556.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS7703.1">
<molecule id="Q92985-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS7704.1">
<molecule id="Q92985-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS7705.1">
<molecule id="Q92985-4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001563.2">
<molecule id="Q92985-1"/>
<property type="nucleotide sequence ID" value="NM_001572.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004020.1">
<molecule id="Q92985-2"/>
<property type="nucleotide sequence ID" value="NM_004029.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004022.2">
<molecule id="Q92985-4"/>
<property type="nucleotide sequence ID" value="NM_004031.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005252963.1">
<property type="nucleotide sequence ID" value="XM_005252906.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016873163.1">
<property type="nucleotide sequence ID" value="XM_017017674.1"/>
</dbReference>
<dbReference type="PDB" id="2O61">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=8-125"/>
</dbReference>
<dbReference type="PDBsum" id="2O61"/>
<dbReference type="SMR" id="Q92985"/>
<dbReference type="BioGRID" id="109873">
<property type="interactions" value="72"/>
</dbReference>
<dbReference type="DIP" id="DIP-34895N"/>
<dbReference type="IntAct" id="Q92985">
<property type="interactions" value="56"/>
</dbReference>
<dbReference type="MINT" id="Q92985"/>
<dbReference type="STRING" id="9606.ENSP00000380697"/>
<dbReference type="iPTMnet" id="Q92985"/>
<dbReference type="PhosphoSitePlus" id="Q92985"/>
<dbReference type="BioMuta" id="IRF7"/>
<dbReference type="DMDM" id="116242593"/>
<dbReference type="MassIVE" id="Q92985"/>
<dbReference type="MaxQB" id="Q92985"/>
<dbReference type="PaxDb" id="Q92985"/>
<dbReference type="PeptideAtlas" id="Q92985"/>
<dbReference type="PRIDE" id="Q92985"/>
<dbReference type="ProteomicsDB" id="75643">
<molecule id="Q92985-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="75644">
<molecule id="Q92985-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="75645">
<molecule id="Q92985-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="75646">
<molecule id="Q92985-4"/>
</dbReference>
<dbReference type="Antibodypedia" id="4325">
<property type="antibodies" value="591 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000330243">
<molecule id="Q92985-4"/>
<property type="protein sequence ID" value="ENSP00000329411"/>
<property type="gene ID" value="ENSG00000185507"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000348655">
<molecule id="Q92985-2"/>
<property type="protein sequence ID" value="ENSP00000331803"/>
<property type="gene ID" value="ENSG00000185507"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000397566">
<molecule id="Q92985-4"/>
<property type="protein sequence ID" value="ENSP00000380697"/>
<property type="gene ID" value="ENSG00000185507"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000469048">
<molecule id="Q92985-3"/>
<property type="protein sequence ID" value="ENSP00000434607"/>
<property type="gene ID" value="ENSG00000185507"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000525445">
<molecule id="Q92985-1"/>
<property type="protein sequence ID" value="ENSP00000434009"/>
<property type="gene ID" value="ENSG00000185507"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000533182">
<molecule id="Q92985-3"/>
<property type="protein sequence ID" value="ENSP00000433903"/>
<property type="gene ID" value="ENSG00000185507"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000612534">
<molecule id="Q92985-4"/>
<property type="protein sequence ID" value="ENSP00000479615"/>
<property type="gene ID" value="ENSG00000276561"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000621391">
<molecule id="Q92985-1"/>
<property type="protein sequence ID" value="ENSP00000480358"/>
<property type="gene ID" value="ENSG00000276561"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000632827">
<molecule id="Q92985-4"/>
<property type="protein sequence ID" value="ENSP00000488039"/>
<property type="gene ID" value="ENSG00000276561"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000633274">
<molecule id="Q92985-3"/>
<property type="protein sequence ID" value="ENSP00000488591"/>
<property type="gene ID" value="ENSG00000276561"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000633943">
<molecule id="Q92985-2"/>
<property type="protein sequence ID" value="ENSP00000488666"/>
<property type="gene ID" value="ENSG00000276561"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000634105">
<molecule id="Q92985-3"/>
<property type="protein sequence ID" value="ENSP00000488581"/>
<property type="gene ID" value="ENSG00000276561"/>
</dbReference>
<dbReference type="GeneID" id="3665"/>
<dbReference type="KEGG" id="hsa:3665"/>
<dbReference type="UCSC" id="uc001lqg.3">
<molecule id="Q92985-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3665"/>
<dbReference type="DisGeNET" id="3665"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000185507.19"/>
<dbReference type="GeneCards" id="IRF7"/>
<dbReference type="HGNC" id="HGNC:6122">
<property type="gene designation" value="IRF7"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000185507">
<property type="expression patterns" value="Tissue enhanced (blood)"/>
</dbReference>
<dbReference type="MalaCards" id="IRF7"/>
<dbReference type="MIM" id="605047">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="616345">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q92985"/>
<dbReference type="OpenTargets" id="ENSG00000185507"/>
<dbReference type="PharmGKB" id="PA29921"/>
<dbReference type="eggNOG" id="ENOG502R2I9">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000160931"/>
<dbReference type="HOGENOM" id="CLU_031544_2_0_1"/>
<dbReference type="InParanoid" id="Q92985"/>
<dbReference type="KO" id="K09447"/>
<dbReference type="OMA" id="HYRKKEM"/>
<dbReference type="OrthoDB" id="648909at2759"/>
<dbReference type="PhylomeDB" id="Q92985"/>
<dbReference type="TreeFam" id="TF328512"/>
<dbReference type="PathwayCommons" id="Q92985"/>
<dbReference type="Reactome" id="R-HSA-3134963">
<property type="pathway name" value="DEx/H-box helicases activate type I IFN and inflammatory cytokines production"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-877300">
<property type="pathway name" value="Interferon gamma signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9013973">
<property type="pathway name" value="TICAM1-dependent activation of IRF3/IRF7"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-909733">
<property type="pathway name" value="Interferon alpha/beta signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-918233">
<property type="pathway name" value="TRAF3-dependent IRF activation pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-933541">
<property type="pathway name" value="TRAF6 mediated IRF7 activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-936964">
<property type="pathway name" value="Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-975110">
<property type="pathway name" value="TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling"/>
</dbReference>
<dbReference type="SignaLink" id="Q92985"/>
<dbReference type="SIGNOR" id="Q92985"/>
<dbReference type="BioGRID-ORCS" id="3665">
<property type="hits" value="6 hits in 894 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="IRF7">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="IRF7"/>
<dbReference type="GenomeRNAi" id="3665"/>
<dbReference type="Pharos" id="Q92985">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q92985"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 11"/>
</dbReference>
<dbReference type="RNAct" id="Q92985">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000185507">
<property type="expression patterns" value="Expressed in right lobe of liver and 203 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q92985">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q92985">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0010008">
<property type="term" value="C:endosome membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990837">
<property type="term" value="F:sequence-specific double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051607">
<property type="term" value="P:defense response to virus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019043">
<property type="term" value="P:establishment of viral latency"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002376">
<property type="term" value="P:immune system process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016064">
<property type="term" value="P:immunoglobulin mediated immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032607">
<property type="term" value="P:interferon-alpha production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032608">
<property type="term" value="P:interferon-beta production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060333">
<property type="term" value="P:interferon-gamma-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0039530">
<property type="term" value="P:MDA-5 signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000110">
<property type="term" value="P:negative regulation of macrophage apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0032727">
<property type="term" value="P:positive regulation of interferon-alpha production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032728">
<property type="term" value="P:positive regulation of interferon-beta production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032481">
<property type="term" value="P:positive regulation of type I interferon production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0060340">
<property type="term" value="P:positive regulation of type I interferon-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002819">
<property type="term" value="P:regulation of adaptive immune response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050776">
<property type="term" value="P:regulation of immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045655">
<property type="term" value="P:regulation of monocyte differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034124">
<property type="term" value="P:regulation of MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034127">
<property type="term" value="P:regulation of MyD88-independent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032479">
<property type="term" value="P:regulation of type I interferon production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009615">
<property type="term" value="P:response to virus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035666">
<property type="term" value="P:TRIF-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0060337">
<property type="term" value="P:type I interferon signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="CDD" id="cd00103">
<property type="entry name" value="IRF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.200.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00491"/>
<dbReference type="InterPro" id="IPR019817">
<property type="entry name" value="Interferon_reg_fac_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001346">
<property type="entry name" value="Interferon_reg_fact_DNA-bd_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR019471">
<property type="entry name" value="Interferon_reg_factor-3"/>
</dbReference>
<dbReference type="InterPro" id="IPR017855">
<property type="entry name" value="SMAD-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR008984">
<property type="entry name" value="SMAD_FHA_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR036388">
<property type="entry name" value="WH-like_DNA-bd_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR036390">
<property type="entry name" value="WH_DNA-bd_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11949">
<property type="entry name" value="PTHR11949"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00605">
<property type="entry name" value="IRF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF10401">
<property type="entry name" value="IRF-3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00267">
<property type="entry name" value="INTFRNREGFCT"/>
</dbReference>
<dbReference type="SMART" id="SM00348">
<property type="entry name" value="IRF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01243">
<property type="entry name" value="IRF-3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF46785">
<property type="entry name" value="SSF46785"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49879">
<property type="entry name" value="SSF49879"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00601">
<property type="entry name" value="IRF_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51507">
<property type="entry name" value="IRF_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0051">Antiviral defense</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Interferon regulatory factor 7" id="PRO_0000154562">
<location>
<begin position="1"/>
<end position="503"/>
</location>
</feature>
<feature type="DNA-binding region" description="IRF tryptophan pentad repeat" evidence="4">
<location>
<begin position="11"/>
<end position="126"/>
</location>
</feature>
<feature type="site" description="(Microbial infection) Cleavage; by viral EV68 protease 3C" evidence="22">
<location>
<begin position="167"/>
<end position="168"/>
</location>
</feature>
<feature type="site" description="(Microbial infection) Cleavage; by viral EV 71 protease 3C and EV68 protease 3C" evidence="20 22">
<location>
<begin position="189"/>
<end position="190"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by KAT2A and KAT2B" evidence="8">
<location>
<position position="92"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="471"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="472"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="475"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by TBK1 and IKKE" evidence="12">
<location>
<position position="477"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by TBK1 and IKKE" evidence="12">
<location>
<position position="479"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="483"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="484"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="487"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)">
<location>
<position position="444"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)">
<location>
<position position="446"/>
</location>
</feature>
<feature type="splice variant" description="In isoform D." id="VSP_002757" evidence="27 29">
<original>MALAPE</original>
<variation>MPVPERPAAGPDSPRPGTR</variation>
<location>
<begin position="1"/>
<end position="6"/>
</location>
</feature>
<feature type="splice variant" description="In isoform C." id="VSP_002758" evidence="28">
<original>GGPPGPFLAHTHA</original>
<variation>AQGSLLGSCTGGQ</variation>
<location>
<begin position="152"/>
<end position="164"/>
</location>
</feature>
<feature type="splice variant" description="In isoform C." id="VSP_002759" evidence="28">
<location>
<begin position="165"/>
<end position="503"/>
</location>
</feature>
<feature type="splice variant" description="In isoform B." id="VSP_002760" evidence="28">
<location>
<begin position="228"/>
<end position="256"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1061502." id="VAR_027957" evidence="25 26">
<original>K</original>
<variation>E</variation>
<location>
<position position="179"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs41313489." id="VAR_061273">
<original>D</original>
<variation>N</variation>
<location>
<position position="204"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD39; loss of function mutation; shows abnormal localization to the cytoplasm rather than the nucleus; dbSNP:rs786205223." id="VAR_073779" evidence="21">
<original>F</original>
<variation>V</variation>
<location>
<position position="410"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1131665." id="VAR_034017" evidence="25">
<original>Q</original>
<variation>R</variation>
<location>
<position position="412"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of acetylation, increased DNA-binding and activity; when associated with R-93." evidence="8">
<original>G</original>
<variation>T</variation>
<location>
<position position="90"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of acetylation, DNA-binding and activity." evidence="8">
<original>K</original>
<variation>R</variation>
<location>
<position position="92"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of acetylation, increased DNA-binding and activity; when associated with T-90." evidence="8">
<original>T</original>
<variation>R</variation>
<location>
<position position="93"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on cleavage by enterovirus 71." evidence="20">
<original>Q</original>
<variation>A</variation>
<location>
<position position="151"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of inactivation of IFN-I production; when associated with R-189." evidence="22">
<original>Q</original>
<variation>A</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on cleavage by enterovirus 71." evidence="20">
<original>Q</original>
<variation>A</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on cleavage by enterovirus 71." evidence="20">
<original>Q</original>
<variation>A</variation>
<location>
<position position="185"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on cleavage by enterovirus 71." evidence="20">
<original>Q</original>
<variation>A</variation>
<location>
<position position="188"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of cleavage by enterovirus 71." evidence="20">
<original>Q</original>
<variation>A</variation>
<location>
<position position="189"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of inactivation of IFN-I production; when associated with A-167." evidence="22">
<original>Q</original>
<variation>R</variation>
<location>
<position position="189"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on cleavage by enterovirus 71." evidence="20">
<original>Q</original>
<variation>A</variation>
<location>
<position position="215"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of TBK1 and IKKE phosphorylation." evidence="12">
<original>SLS</original>
<variation>ALA</variation>
<location>
<begin position="477"/>
<end position="479"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="14"/>
<end position="24"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="31"/>
<end position="36"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="39"/>
<end position="43"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="55"/>
<end position="57"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="58"/>
<end position="66"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="84"/>
<end position="102"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="105"/>
<end position="112"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="119"/>
<end position="125"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2O61"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250"/>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P70434"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00840"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11073981"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11314014"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11943871"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12374802"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14517278"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14739303"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15361868"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15367631"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15492225"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15767370"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17301153"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17404045"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18987133"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19017798"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21940674"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23175366"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25814066"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26608321"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28768861"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29427864"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9786932"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source ref="1"/>
</evidence>
<evidence key="27" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9315633"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9786932"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000305"/>
<sequence length="503" mass="54278" checksum="9863C147514652DE" modified="2006-10-17" version="2">MALAPERAAPRVLFGEWLLGEISSGCYEGLQWLDEARTCFRVPWKHFARKDLSEADARIFKAWAVARGRWPPSSRGGGPPPEAETAERAGWKTNFRCALRSTRRFVMLRDNSGDPADPHKVYALSRELCWREGPGTDQTEAEAPAAVPPPQGGPPGPFLAHTHAGLQAPGPLPAPAGDKGDLLLQAVQQSCLADHLLTASWGADPVPTKAPGEGQEGLPLTGACAGGPGLPAGELYGWAVETTPSPGPQPAALTTGEAAAPESPHQAEPYLSPSPSACTAVQEPSPGALDVTIMYKGRTVLQKVVGHPSCTFLYGPPDPAVRATDPQQVAFPSPAELPDQKQLRYTEELLRHVAPGLHLELRGPQLWARRMGKCKVYWEVGGPPGSASPSTPACLLPRNCDTPIFDFRVFFQELVEFRARQRRGSPRYTIYLGFGQDLSAGRPKEKSLVLVKLEPWLCRVHLEGTQREGVSSLDSSSLSLCLSSANSLYDDIECFLMELEQPA</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

